Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Intestinal parasites" is a broad, non-molecular term that refers to various pathogenic organisms—including protozoa like *Giardia duodenalis*, *Entamoeba histolytica*, *Blastocystis sp.*, and helminths such as hookworms, roundworms, and whipworms—that inhabit the human gastrointestinal tract and cause disease. They are associated with diarrheal illnesses, nutritional deficiencies, and various systemic complications. Therapeutic interventions target specific parasite metabolic pathways, enzymes, structural proteins, or neural systems rather than a single unified molecular target. Multiple drugs and drug classes with different mechanisms of action are used to treat these infections, and ongoing research is identifying parasite-specific biomolecular targets for future therapy.
inhibition of microtubule polymerization (e.g., benzimidazoles); disruption of parasite metabolism; inhibition of heme detoxification; inhibition of nucleic acid and protein synthesis; oxidative damage to parasite cells; paralysis of parasite nervous/muscular systems
17 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal parasites.